Lower riskDrug recall · FDA · Published July 13, 2020
Fresenius Kabi Fosaprepitant Injection Recall: Labeling Error in EDTA Quantity
Fresenius Kabi recalls Fosaprepitant injection vials with incorrect EDTA labeling. This labeling error may affect medication accuracy. Affected vials have specific NDC and lot numbers. Contact for details.
Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.
Take action
Contact the company
📍Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
“Fresenius Kabi Fosaprepitant Injection Recall: Labeling Error in EDTA Quantity.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36935-fresenius-kabi-fosaprepitant-injection-recall-labeling-error-in-edta-quantity. Based on FDA recall #D-1391-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1391-2020%22&limit=1).
Fresenius Kabi USA, LLC voluntarily recalled Fosaprepitant for Injection due to a labeling error stating an incorrect quantity of edetate disodium, according to the FDA on July 13, 2020.
How to tell if you have it
Brand: Fresenius Kabi
Product: Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial
The carton label and product insert incorrectly state the quantity of the excipient edetate disodium as 5.4 mg / vial instead of the actual amount of 18.8 mg / vial.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls include a Tyenne Injection recall for glass particles (August 10, 2026), Morphine Syringes with wrong labeling (August 4, 2026), and Lidocaine HCl Injection with hair found in products (July 16, 2026). Other recent recalls of similar products include an American Regent Levocarnitine Injection recall for a missing label (April 16, 2026), a Slate Run Eptifibatide Injection recall due to labeling error (February 12, 2026), and an Otsuka ICU Medical Potassium Chloride Inj. 20mEq Label Error Recall (October 29, 2025).
How to tell if you have this one
Check for vials with NDC 63323-972-10, lot numbers 6122760, 6122761 (exp 08/2021), 6122762 (exp 09/2021), or 6123883 (exp 03/2022). These vials are labeled with incorrect EDTA quantities.
Brand
Fresenius Kabi
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Verify the EDTA quantity on the label; if it shows 5.4 mg instead of 18.8 mg, this vial is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1391-2020 (July 13, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1391-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.